These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. Herrmann K, Heckmann M, Kulozik M, Haustein UF, Krieg T. J Invest Dermatol; 1991 Aug; 97(2):219-22. PubMed ID: 1649227 [Abstract] [Full Text] [Related]
5. Elevated pro alpha 2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene. Kähäri VM, Multimäki P, Vuorio E. FEBS Lett; 1987 May 11; 215(2):331-4. PubMed ID: 3582658 [Abstract] [Full Text] [Related]
6. Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients. Lapoirie J, Tran L, Piazza L, Contin-Bordes C, Truchetet ME, Bonnet F. Sci Rep; 2021 Sep 09; 11(1):18011. PubMed ID: 34504265 [Abstract] [Full Text] [Related]
7. Transcriptional activation of the alpha 1(I) procollagen gene in systemic sclerosis dermal fibroblasts. Role of intronic sequences. Hitraya EG, Jiménez SA. Arthritis Rheum; 1996 Aug 09; 39(8):1347-54. PubMed ID: 8702443 [Abstract] [Full Text] [Related]
9. Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts. Vuorio T, Mäkelä JK, Kähäri VM, Vuorio E. Arch Dermatol Res; 1987 Aug 09; 279(3):154-60. PubMed ID: 3592743 [Abstract] [Full Text] [Related]
13. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM. Arthritis Rheum; 1998 Nov 01; 41(11):2039-47. PubMed ID: 9811060 [Abstract] [Full Text] [Related]
14. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate. Dooley A, Shi-Wen X, Aden N, Tranah T, Desai N, Denton CP, Abraham DJ, Bruckdorfer R. Rheumatology (Oxford); 2010 Nov 01; 49(11):2024-36. PubMed ID: 20627968 [Abstract] [Full Text] [Related]
19. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts. Yamamoto T, Eckes B, Krieg T. Arch Dermatol Res; 2000 Nov 01; 292(11):556-61. PubMed ID: 11194894 [Abstract] [Full Text] [Related]
20. The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis. Czuwara-Ladykowska J, Makiela B, Smith EA, Trojanowska M, Rudnicka L. Arthritis Res; 2001 Nov 01; 3(5):311-8. PubMed ID: 11549373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]